Skip to content
Nonprofiteer
← All organizations

LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN

EIN 58-2404527 NEW YORK, NY

Revenue 2025
$1,283,221
Expenses 2025
$1,770,505

Program services were 81.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

As filed

Subsection
03
NTEE code
H90
Classification
1000
Street
154 W 14TH STREET

These codes are the IRS's own and are shown exactly as filed. What each one means is in the Business Master File documentation (opens in a new tab).

Mission and programs · 2025

Mission

THE ORGANIZATION'S MISSION IS TO FIGHT LYMPHATIC DISEASES AND LYMPHEDEMA THROUGH EDUCATION, RESEARCH AND ADVOCACY. THE ORGANIZATION SEEKS TO ACCELERATE THE PREVENTION, TREATMENT, AND CURE OF LYMPHATIC DISEASES WHILE BRINGING PATIENTS AND MEDICAL PROFESSIONALS TOGETHER TO ADDRESS THE UNMET NEEDS SURROUNDING LYMPHATIC DISORDERS.

Activities or mission (Part I)

THE ORGANIZATION'S MISSION IS TO FIGHT LYMPHATIC DISEASE AND LYMPHEDEMA THROUGH EDUCATION, RESEARCH AND ADVOCACY. THE ORGANIZATION SEEKS TO ACCELERATE THE PREVENTION, TREATMENT, AND CURE OF LYMPHATIC DISEASES WHILE BRINGING PATIENTS AND MEDICAL PROFESSIONALS TOGETHER TO ADDRESS THE UNMET NEEDS SURROUNDING LYMPHATIC DISORDERS.

  • Some activities of the organization during 2025 include the following: LE&RN continued to expand programs to meet the goals of the expanded mission of fighting lymphatic disease through education, research, and advocacy. LE&RN continued its grant program, which allows young investigators to attend conferences focused on lymphatic research. LE&RN continued its educational and awareness outreach programs targeting academia, government, industry, and the medical and patient communities. LE&RN continued its monthly virtual symposium series, which brings the world's foremost authorities in lymphatic disease and lymphedema to patients, their families, and professionals. LE&RN updated its website and provided daily social media posts and monthly newsletters featuring significant events in the field. LE&RN produced six issues of Lymphatic Research and Biology, an international, peer-reviewedbiomedical journal providing a forum for the exchange of cutting-edge scientific developments in lymphatic science and medicine. LE&RN secured ongoing support from the Congressional and National Institutes of Health for lymphatic research. LE&RN continued the LE&RN/LymphNotes Lymphedema Scholarship Program to provide tuition support to therapists seeking certification in lymphedema therapy. LE&RN continued a web-based "Ask the Experts" feature that allows patients, their families, and professionals to ask the most prominent authorities in the field questions directly. LE&RN spokesperson and Academy Award Winner Kathy Bates appeared in print and television media to support research. LE&RN's Virtual Expo was expanded to better serve patients and therapists. LE&RN and NAVBO prepared a biennial Virtual Lymphatic Forum for researchers LE&RN developed new chapters in several states and countries. LE&RN continued to lead global events related to its establishment of World Lymphedema Day on March 6, 2016. LE&RN supported and grew its Centers of Excellence in the Diagnosis & Treatment of Lymphatic Diseases to 80 member institutions in over 20 countries. LE&RN, in collaboration with Stanford University, hosted the annual virtual State-of-the-Art Summit in Lymphatic Research & Medicine. LE&RN promoted its PSA video featuring National Spokesperson Kathy Bates, which was hosted on the Centers for Disease Control and Prevention (CDC) 's cancer-related websites. LE&RN continued its cancer-related lymphedema campaign. LE&RN succeeded in having the Congressionally Directed Medical Research Program (CDMRP) include lymphedema as a category in the Department of Defense's Peer Reviewed Medical Research Program (PRMRP). LE&RN successfully requested that Congress establish a National Commission on Lymphatic Diseases at the National Institutes of Health (NIH). LE&RN established a global Patient Resource Center. LE&RN expanded and updated its Global Patient Registry. LE&RN successfully advocated for a Program Manager in Lymphatics at the Advanced Research Agency for Health (ARPA-H) LE&RN, in concert with the research community, created a "Gaps in Lymphatic Research" document that was distributed to the NIH, CDC, ARPA-H, CDMRP, NNLBI, and NIAID. LE&RN hired its first full-time Vice President of Scientific Affairs and Science and Medical Director.

    Expenses $1,442,732 · Grants $23,618 · Revenue $1,169,710

As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.

Officers and directors · 2025

As listed in Part VII of the 2025 return, in the order the filer printed them. Each return names its own; this is not a roster the organization keeps with us.

  • JOSEPH DAYAN MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • DORON ILAN MD

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • DAVE MCDOWELL

    CHAIRPERSON

    Total calculated
    $0
    Hours/week
    10

  • RICK PETTY

    DIRECTOR

    Total calculated
    $0
    Hours/week
    1

  • DEBBIE MILES

    TREASURER

    Total calculated
    $0
    Hours/week
    1

  • MELISSA ALDRICH PHD

    SECRETARY

    Total calculated
    $0
    Hours/week
    1

  • WILLIAM REPICCI

    PRESIDENT & CEO

    Total calculated
    $372,407
    From this org
    $314,640
    From related orgs
    $0
    Other
    $57,767
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $283,640
    Bonus
    $0
    Other
    $31,000
    Deferred
    $30,000
    Nontaxable benefits
    $27,767
    Filer's total
    $372,407

  • Maria Celia Dupecher

    Vice President for Scientific Affairs

    Total calculated
    $146,250
    From this org
    $146,250
    From related orgs
    $0
    Other
    $0
    Hours/week
    40

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us. Earlier years are each on their own filing page.

Filings

  • 2025
    Revenue
    $1,283,221
    Expenses
    $1,770,505
    Contributions
    $1,142,651
    Grants paid
    $23,618
  • 2025
    Revenue
    $1,283,221
    Expenses
    $1,770,505
    Contributions
    $1,142,651
    Grants paid
    $23,618
  • 2024
    Revenue
    $1,755,810
    Expenses
    $1,651,386
    Contributions
    $1,558,455
    Grants paid
    $13,348
  • 2023
    Revenue
    $1,476,365
    Expenses
    $1,736,198
    Contributions
    $1,391,048
    Grants paid
    $17,000
  • 2022
    Revenue
    $1,462,533
    Expenses
    $1,490,145
    Contributions
    $1,346,987
    Grants paid
    $9,000

The four totals the IRS asks for on Part I of the Form 990, as filed. A dash means the figure was not present on the return — not that it was zero.

Other returns filed

  • 2021 · 990

    Revenue
    $4,129,686
    Expenses
    $997,532
    Assets (EOY)
    $3,889,093

  • 2020 · 990

    Revenue
    $894,003
    Expenses
    $731,503
    Assets (EOY)
    $654,052

  • 2019 · 990

    Revenue
    $1,001,853
    Expenses
    $866,648
    Assets (EOY)
    $501,469

  • 2018 · 990

    Revenue
    $912,615
    Expenses
    $867,921
    Assets (EOY)
    $352,714

  • 2017 · 990

    Revenue
    $617,641
    Expenses
    $824,266
    Assets (EOY)
    $264,626

  • 2016 · 990

    Revenue
    $635,364
    Expenses
    $927,227
    Assets (EOY)
    $435,545

Nonprofiteer parses Forms 990, 990-EZ and 990-PF, in a window of recent tax years. These returns are recorded from the IRS e-file index, so their figures were extracted by that index rather than read from the return here — treat them as a different source from the filings above, not as more of the same record. A dash means the index carries no figure; Form 990-T listings carry none at all.

Grants made

No itemized grants to organizations. Schedule I is filed only by organizations that granted more than $5,000 to a recipient, so most filers have none.

Grants received

The 10 largest by cash amount. The API serves every itemized grant.

Other IRS files

Auto-Revocation List

Not listed. The IRS publishes this list for organizations whose exemption was automatically revoked for failing to file for three consecutive years.

Publication 78

Listed as of 13 October 2026, under deductibility PC.

These are two separate IRS files on two separate schedules, shown as published and not reconciled with each other. Neither is a statement about whether a contribution is deductible today: 19,245 organizations appear in Publication 78 while the IRS's own revocation file lists them as currently revoked, more than half of those revoked before 2019. Absence from Publication 78 is evidence of nothing, and presence is not evidence either. Verify current status with the IRS before relying on it.

What this page reflects

The registration facts above come from the IRS Business Master File published 13 October 2026 and read 23 October 2026, for every organization at once. Returns through tax year 2025, the newest we have parsed for this organization.